Article Text
Commentary
A unique monoclonal antibody for therapeutic use against chronic hepatitis B: not all antibodies are created equal
Statistics from Altmetric.com
Footnotes
Competing interests CS is a CNRS scientist and he is supported by Agence Nationale pour la Recherche sur le SIDA et les hépatites virales (ANRS).
Provenance and peer review Commissioned; internally peer reviewed.